• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Life-Sciences-Germany.com
The Life Sciences Web Portal for German-speaking Europe

This is a free web portal for the life sciences in German-speaking Europe... » read more

• Cytosurge Spins Off Its 3D Printing Business Unit (2019-08-21)
  The 3D Printing business unit of Cytosurge has been recognized as the technological global market leader for additive manufacturing of microscopically small metal components. We are pleased to announce as of today that all 3D Printing activities of Cytosurge will b...
• Araris Biotech Raises CHF2.5m Seed Financing Round (2019-08-20)
  > Redalpine, Schroder Adveq and VI Partners participated in round > Proceeds to support development of own antibody-drug-conjugates (ADCs) Araris Biotech AG announced today the closing of an oversubscribed seed financing round of CHF 2.5 million with parti...
• Eppendorf AG Announces Results for First Half of 2019 (2019-08-20)
  > At €66.7 million, income from operations is at prior-year level > Strong growth in all sales regions and product groups > Targets for the entire year are confirmed The globally active Eppendorf Group charted a strong first half-year in 2019 with a si...
• Bayer to Sell Animal Health Business to Elanco for $7.6b (2019-08-20)
  Exit of Animal Health business completes the series of portfolio measures initiated by Bayer in November 2018 ahead of announced schedule / Enhances Bayer’s focus as a global leader in life sciences U.S.-based company Elanco Animal Health has entered into a de...
• Nabriva: FDA Approves Xenleta (lefamulin) for CABP (2019-08-19)
  > First New IV and Oral Antibiotic with a Novel Mechanism of Action Approved in Nearly Two Decades Provides Critically Needed Treatment Option for Adult Patients with CABP > XENLETA Expected to be Available mid-September 2019 > Conference call and webcast t...
• Genentech and Roche Appoint Levi Garraway as CMO (2019-08-19)
  Dr. Sandra Horning, Chief Medical Officer and Head of Global Product Development will retire on December 31, 2019. During her decade-long tenure with Roche and Genentech, Dr. Horning brought 15 new medicines to patients and tackled some of the world’s toughest dise...
• Roche: FDA Approves Rozlytrek (entrectinib) for Two Cancers (2019-08-16)
  > First FDA-approved treatment designed to target both ROS1 and NTRK that also shows response in cancer that has spread to the brain > Roche’s first FDA-approved tumour-agnostic medicine Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food an...
• Lundbeck Appoints Elise Hauge EVP, People & Communication (2019-08-14)
  H. Lundbeck A/S (Lundbeck) today announced the appointment of Elise Hauge to the role of EVP, People & Communication. Elise will join Lundbeck on 1 September 2019 and will be part of Executive Management. Elise will be responsible for driving Lundbeck’s people s...
• Pharming Acquires Late Stage Orphan Drug from Novartis (2019-08-13)
  > CDZ173 is in a registration-enabling study for the treatment of APDS, an ultra-rare, debilitating disease with no approved treatment > APDS is treated by immunologists; the main physicians treating HAE and therefore already addressed by Pharming > Upfront p...
• Boehringer & MD Anderson Form Virtual Oncology RnD Center (2019-08-12)
  > New potential gastrointestinal and lung cancer therapies from Boehringer Ingelheim’s innovative oncology pipeline will be combined with the patient-driven drug-development capabilities at MD Anderson > The Center will initially investigate KRAS pathway inhibi...

» Show all News!"

Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!

[LSG] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations


in Germany, Austria and Switzerland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!

Start here with the latest News!

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.